25th International Workshop on Long-term Complications of HIV and SARS-CoV-2
第 25 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会
基本信息
- 批准号:10828053
- 负责人:
- 金额:$ 6.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-16 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAdverse effectsAffectAgeCOVID-19COVID-19 pandemicCardiovascular DiseasesCause of DeathChronicChronic DiseaseClinicalCollaborationsCommunitiesDisciplineDiseaseEducational workshopEtiologyEuropeFeedbackFosteringFunding OpportunitiesGoalsGrantHIVHIV InfectionsHomeInflammationInternationalLearningLiver diseasesLong COVIDLongevityMalignant NeoplasmsMarylandNIH Office of AIDS ResearchNamesNational Institute of Allergy and Infectious DiseaseOralPathogenesisPathogenicityPatientsPersonsPhysiologicalPlayPost-Acute Sequelae of SARS-CoV-2 InfectionResearchResearch PersonnelResourcesRisk FactorsRoleScheduleScholarshipScienceSymptomsSyndromeSystemTraining ProgramsTranslational ResearchTravelUnited States National Institutes of HealthWorkWritingacute infectionantiretroviral therapycareer developmentclinical practicecomorbiditycoronavirus diseasedesigndisabilityhealthspanimprovedinnovationinterestlow and middle-income countriesmeetingsmultidisciplinarypeerpersistent symptompostersprogramsskillssuccessvirtual
项目摘要
With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes
of death and disability in people living with HIV around the globe, including in low- and middle-
income countries (LMIC). Large meetings are important venues for scientific exchange regarding
the latest advances in HIV Comorbidity research, but smaller, more intimate formats that
emphasize discussion and networking are critical to the career development of HIV Comorbidity
investigators. In addition, there is a need for a forum for scientific exchange regarding post-acute
sequelae of COVID-19 (PASC), a poorly understood syndrome which may share pathogenic
features with HIV comorbidities and, as a result, has attracted the interest of many HIV
Comorbidity researchers. Our workshop, now in its 25th year and renamed the International
Workshop on Long-term Complications of HIV and SARS-CoV-2, provides <200 international
delegates with an opportunity to come together to discuss the latest findings and controversies in
HIV Comorbidity and PASC research in a one-room, two-day format. Plenary speakers are either
noted experts from outside of HIV research or HIV researchers with expertise in a specific
comorbidity. A highly interactive PASC roundtable, with 2 mini-talks, highlights critical and
emerging issues in the pathogenesis and management of PASC. Abstract presentations
including 24 15-minute talks and a poster session provide ample opportunity for researchers to
present and get feedback on their latest work. With this R13, we propose to enhance the 25th
Workshop (December 14th/15th at the NIH in Rockville, MD) with the following aims: 1) to provide
a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC
investigators, supporting an internationally recognized expert in non-communicable diseases in
LMIC as a plenary speaker, and liaising with international training programs, 2) to provide a
continued and expanded forum for discussion and dissemination of the latest research findings
regarding PASC, 3) to support early-stage HIV Comorbidity and PASC investigators with a highly
innovative day-long Career Development Studio prior to the Workshop (December 13th). By
providing a “scientific home” to HIV Comorbidity and PASC investigators from around the world,
we hope to catalyze future research efforts in HIV Comorbidities and PASC and facilitate the
translation of research findings into clinical strategies that can improve the lifespan and
healthspan of PLWH and those with long COVID.
随着抗逆转录病毒疗法(ART)的成功,合并症现在是主要原因
地球仪各地艾滋病毒感染者的死亡和残疾率,包括中低收入者和
收入国家(LMIC)。大型会议是科学交流的重要场所,
艾滋病研究的最新进展,但更小,更亲密的格式,
强调讨论和建立网络对艾滋病毒感染者的职业发展至关重要
investigators.此外,需要建立一个论坛,就急性期后
COVID-19(PASC)的后遗症,这是一种知之甚少的综合征,可能与其他疾病的致病性
与艾滋病毒合并症的特点,因此,吸引了许多艾滋病毒感染者的兴趣,
科摩罗研究人员。我们的研讨会,现在在其第25个年头,并更名为国际
艾滋病毒和SARS-CoV-2长期并发症研讨会,提供<200名国际
代表们有机会聚在一起讨论最新的调查结果和争议,
艾滋病毒科摩罗和PASC研究在一个房间,两天的格式。全体发言人是
来自艾滋病毒研究之外的知名专家或在特定领域具有专业知识的艾滋病毒研究人员
科摩罗。一个高度互动的PASC圆桌会议,包括2个小型会谈,突出了关键和
PASC的发病机制和管理中出现的问题。摘要介绍
包括24个15分钟的演讲和海报会议,为研究人员提供了充足的机会,
展示并获得他们最新工作的反馈。有了这个R13,我们建议加强25日
研讨会(12月14日/15日在马里兰州罗克维尔的NIH举行),目的如下:1)提供
通过向LMIC提供旅行奖学金,为LMIC最新的艾滋病研究提供论坛
调查员,支持国际公认的非传染性疾病专家,
LMIC作为全体会议发言人,并与国际培训计划联系,2)提供一个
继续和扩大论坛,讨论和传播最新研究成果
关于PASC,3)支持早期HIV感染者和PASC研究人员,
创新的为期一天的职业发展工作室之前,讲习班(12月13日)。通过
为来自世界各地的艾滋病毒感染者和PASC研究人员提供一个“科学之家”,
我们希望促进未来在艾滋病合并症和PASC方面的研究工作,
将研究结果转化为临床策略,可以提高寿命,
艾滋病毒携带者和长期COVID患者的健康状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TODD T BROWN其他文献
TODD T BROWN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TODD T BROWN', 18)}}的其他基金
24th International Workshop on Long-term Complications of HIV and SARS-CoV-2
第 24 届艾滋病毒和 SARS-CoV-2 长期并发症国际研讨会
- 批准号:
10548510 - 财政年份:2022
- 资助金额:
$ 6.83万 - 项目类别:
23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV
第23届艾滋病毒合并症和药物不良反应年度国际研讨会
- 批准号:
10327072 - 财政年份:2021
- 资助金额:
$ 6.83万 - 项目类别:
22nd International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV
第22届艾滋病毒合并症和药物不良反应国际研讨会
- 批准号:
10082909 - 财政年份:2020
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10370339 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10220553 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10462255 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10658086 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10213917 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
9903475 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心 - 巴尔的摩/华盛顿特区中心
- 批准号:
10223578 - 财政年份:2019
- 资助金额:
$ 6.83万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 6.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 6.83万 - 项目类别:
Standard Grant